Greenwich Wealth Management LLC - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 57 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q4 2016. The put-call ratio across all filers is 6.52 and the average weighting 0.0%.

Quarter-by-quarter ownership
Greenwich Wealth Management LLC ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q1 2018$15,000
-31.8%
41,403
-31.1%
0.00%
-50.0%
Q4 2017$22,000
-12.0%
60,0660.0%0.00%0.0%
Q3 2017$25,000
-19.4%
60,0660.0%0.00%
-20.0%
Q2 2017$31,000
-11.4%
60,0660.0%0.01%0.0%
Q1 2017$35,000
-7.9%
60,0660.0%0.01%0.0%
Q4 2016$38,000
-30.9%
60,0660.0%0.01%
-50.0%
Q3 2016$55,000
-97.6%
60,066
-50.0%
0.01%
-96.1%
Q2 2016$2,257,000
+3600.0%
120,132
+84.6%
0.26%
+1506.2%
Q1 2016$61,000
-29.9%
65,0660.0%0.02%
-23.8%
Q4 2015$87,000
-41.2%
65,0660.0%0.02%
-41.7%
Q3 2015$148,000
+41.0%
65,0660.0%0.04%
+176.9%
Q2 2015$105,000
+1.9%
65,0660.0%0.01%
+8.3%
Q1 2015$103,000
-16.3%
65,0660.0%0.01%
+50.0%
Q4 2014$123,000
+32.3%
65,066
-7.7%
0.01%
+33.3%
Q3 2014$93,000
-10.6%
70,5000.0%0.01%
-14.3%
Q2 2014$104,000
-20.0%
70,5000.0%0.01%
-22.2%
Q1 2014$130,000
-11.0%
70,5000.0%0.01%
-40.0%
Q4 2013$146,000
-21.9%
70,5000.0%0.02%
+15.4%
Q3 2013$187,000
-0.5%
70,5000.0%0.01%
-7.1%
Q2 2013$188,00070,5000.01%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q4 2016
NameSharesValueWeighting ↓
Platinum Management (NY) LLC 15,575,946$14,711,00089.51%
Financial Advisory Group 10,000$356,0000.17%
COMMERZBANK AKTIENGESELLSCHAFT /FI 6,704,067$6,332,0000.05%
LifePlan Financial Group, Inc 28,810$27,0000.02%
Greenwich Wealth Management LLC 65,066$61,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 649,880$614,0000.01%
LYNCH & ASSOCIATES/IN 18,000$17,0000.01%
SII INVESTMENTS INC/WI 90,315$86,0000.01%
Stratos Wealth Partners, LTD. 42,535$40,0000.00%
SVB WEALTH LLC 46,262$44,0000.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders